These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

209 related articles for article (PubMed ID: 6799077)

  • 1. One year's treatment with propranolol after myocardial infarction: preliminary report of Norwegian multicentre trial.
    Hansteen V; Møinichen E; Lorentsen E; Andersen A; Strøm O; Søiland K; Dyrbekk D; Refsum AM; Tromsdal A; Knudsen K; Eika C; Bakken J; Smith P; Hoff PI
    Br Med J (Clin Res Ed); 1982 Jan; 284(6310):155-60. PubMed ID: 6799077
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Beta blockade after myocardial infarction: the Norwegian propranolol study in high-risk patients.
    Hansteen V
    Circulation; 1983 Jun; 67(6 Pt 2):I57-60. PubMed ID: 6342841
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of propanolol in patients entered in the Beta-Blocker Heart Attack Trial with their first myocardial infarction and persistent electrocardiographic ST-segment depression.
    Shivkumar K; Schultz L; Goldstein S; Gheorghiade M
    Am Heart J; 1998 Feb; 135(2 Pt 1):261-7. PubMed ID: 9489974
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A randomized trial of propranolol in patients with acute myocardial infarction. I. Mortality results.
    JAMA; 1982 Mar; 247(12):1707-14. PubMed ID: 7038157
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Randomised trial comparing propranolol with atenolol in immediate treatment of suspected myocardial infarction.
    Wilcox RG; Roland JM; Banks DC; Hampton JR; Mitchell JR
    Br Med J; 1980 Mar; 280(6218):885-8. PubMed ID: 6992916
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Propranolol therapy in patients with acute myocardial infarction: the Beta-Blocker Heart Attack Trial.
    Goldstein S
    Circulation; 1983 Jun; 67(6 Pt 2):I53-7. PubMed ID: 6342840
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Propranolol and the morning increase in sudden cardiac death: (the beta-blocker heart attack trial experience).
    Peters RW
    Am J Cardiol; 1990 Nov; 66(16):57G-59G. PubMed ID: 2239715
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Norwegian Multicenter Study of Timolol after Myocardial Infarction.
    Pedersen TR
    Circulation; 1983 Jun; 67(6 Pt 2):I49-53. PubMed ID: 6342838
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Chronic beta blockade therapy in patients after myocardial infarction.
    Pratt CM; Roberts R
    Am J Cardiol; 1983 Oct; 52(7):661-4. PubMed ID: 6137945
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mortality in the beta blocker heart attack trial: circumstances surrounding death.
    Peters RW; Byington R; Arensberg D; Friedman LM; Romhilt DW; Barker A; Laubach C; Wilner GW; Goldstein S
    J Chronic Dis; 1987; 40(1):75-82. PubMed ID: 3543049
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A randomized trial of propranolol in patients with acute myocardial infarction. II. Morbidity results.
    JAMA; 1983 Nov; 250(20):2814-9. PubMed ID: 6358542
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Abrupt withdrawal of beta-blockade therapy in patients with myocardial infarction: effects on infarct size, left ventricular function, and hospital course.
    Croft CH; Rude RE; Gustafson N; Stone PH; Poole WK; Roberts R; Strauss HW; Raabe DS; Thomas LJ; Jaffe AS
    Circulation; 1986 Jun; 73(6):1281-90. PubMed ID: 3009050
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Multicentre post-infarction trial of propranolol in 49 hospitals in the United Kingdom, Italy, and Yugoslavia.
    Baber NS; Evans DW; Howitt G; Thomas M; Wilson T; Lewis JA; Dawes PM; Handler K; Tuson R
    Br Heart J; 1980 Jul; 44(1):96-100. PubMed ID: 7000100
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The Timolol Myocardial Infarction Study: an evaluation of selected variables.
    Rodda BE
    Circulation; 1983 Jun; 67(6 Pt 2):I101-6. PubMed ID: 6342836
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Norwegian propranolol trial in selected patients.
    Hansteen V
    Br J Clin Pharmacol; 1982; 14 Suppl 1(Suppl 1):9S-12S. PubMed ID: 7052112
    [No Abstract]   [Full Text] [Related]  

  • 16. Sulfinpyrazone in the prevention of sudden death after myocardial infarction.
    Anturane Reinfarction Trial Research Group
    N Engl J Med; 1980 Jan; 302(5):250-6. PubMed ID: 6985706
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Propranolol and the morning increase in the frequency of sudden cardiac death (BHAT Study).
    Peters RW; Muller JE; Goldstein S; Byington R; Friedman LM
    Am J Cardiol; 1989 Jun; 63(20):1518-20. PubMed ID: 2729140
    [No Abstract]   [Full Text] [Related]  

  • 18. Beta blocking agents: current status in the prevention of sudden coronary death.
    Hjalmarson A
    Ann N Y Acad Sci; 1982; 382():305-23. PubMed ID: 6123286
    [No Abstract]   [Full Text] [Related]  

  • 19. Oxprenolol in myocardial infarction survivors: brief review of the European Infarction Study results in the light of other beta-blocker post infarction trials.
    Schröder R
    Z Kardiol; 1985; 74 Suppl 6():165-72. PubMed ID: 2869616
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The use of beta blockers for the reduction of mortality after myocardial infarction.
    Hampton JR
    Eur Heart J; 1981 Aug; 2(4):259-68. PubMed ID: 6117465
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 11.